Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-01

Study Completion Date

2017-11-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence of Hemidiaphragmatic Palsy After Interscalene Block

NCT01784601

Phrenic Nerve Paralysis

SUSPENDED

Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis

NCT02631122

Phrenic Nerve Paralysis

COMPLETED NA

Magnetic Resonance Imaging of Interscalene Plexus Block

NCT02175069

Disorder of Shoulder

COMPLETED PHASE4

Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block

NCT04209504

Shoulder Surgery Shoulder Pain Shoulder Injuries +7 more

RECRUITING

Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block

NCT01334619

Upper Extremity Injury Trauma

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug. To see hemidiaphragmatic paralysis by seeing diaphragmatic excursion on M mode Usg subcostal approach, to see post operative pain, patient satisfaction score, complications if any

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Two groups: 1- block + GA 2- GA with multimodal analgesia

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

block

will be given block and continuous infusion with bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine

Group Type EXPERIMENTAL

Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml

Intervention Type DEVICE

bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine

control

IV analgesia only with diclofenac and paracetamol

Group Type EXPERIMENTAL

IV diclofenac and IV paracetamol

Intervention Type DRUG

iv diclofenac 75 mg TDS iv paracetamol 1gm TDS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml

bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine

Intervention Type DEVICE

IV diclofenac and IV paracetamol

iv diclofenac 75 mg TDS iv paracetamol 1gm TDS

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ROPIN vovran and perfalgan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18-65 years and belonging to ASA grade I, II, III, undergoing either, shoulder surgery, (rotator cuff repair, acromioplasty, hemiarthroplasty, and total shoulder replacement) or surgery for proximal humerus fracture will be recruited for the study.

Exclusion Criteria

* a) Patient refusal for interscalene block b) Severe respiratory disease (FEV1/FVC \<0.7 and FEV1 \< 80% of predicted) c) Allergy to amide local anaesthetic drugs d) Chronic opioid therapy e) Patients who cannot understand how to operate PCA and VAS

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes